High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

With AI use on the rise, clinical development is also not far behind in using AI technology. AI is actively changing how ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant approach to determine clonal tumor mutation ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

Genmab has stopped clinical development of a blood cancer treatment after Johnson & Johnson decided it won't exercise its option to license it.

Medical has completed the integration and design enhancements of the Apex 6 Generator into a fully integrated transvascular ...

Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.